Genetron Holdings Ltd is an oncology company in China. It is specialized in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. The company generates revenue through precision oncology testing and development services. Precision oncology testing includes the diagnosis and monitoring and early screening performed in the form of LDT services and IVD products. Development services consist of research services and sequencing services.